Table 2.
Summary of Evidence for Statistically Significant (P < 0.05) Positive Correlations between Risk Factors and Complications
| Reference | Summary | Diabetes | Smoking Habit | Age ≥ 40 Years | BMI | Combined Procedures | Male Gender |
|---|---|---|---|---|---|---|---|
| Winocour et al7 | A prospective cohort of 129,007 patients over a 5-year period using data from the CosmetAssure database | VTE (RR 1.02) | VTE (RR 1.06), major complications (RR 1.21) | VTE (RR 2.4) | |||
| Theocharidis et al9 | A systematic review and meta-analysis of 53 studies | Cutaneous necrosis (OR 4.78, RR 0.83); DWH (OR 2.80, RR 0.74); major complications (OR 2.36, RR 0.70) | |||||
| Hillam et al10 | Data on 13,984 patients from the 2009 to 2014 American College of Surgeons National Surgical Quality Improvement Program | Any complication (RR 0.63) | |||||
| Keyes et al11 | A retrospective analysis of 6,388,744 patients over a 10-year period from the IBQAP database | VTE (OR 0.67) | VTE (OR 0.43) | ||||
| Kaoutzanis et al35 | A prospective cohort of patients who underwent liposuction between 2008 and 2013 from the CosmetAssure database | VTE (RR 1.02); major complications (RR 1.01) | VTE (RR 1.06); major complications (RR 1.05) | VTE (RR 5.65); major complications (RR 4.81); SSI (RR 2.41) | |||
| Kaoutzanis et al12 | Five-year prospective cohort review of 129,007 patients from the CosmetAssure database | Hematoma (RR 1.01) | Hematoma (RR 1.35) | ||||
| Layliev et al3 | Five-year prospective cohort review of 129,007 patients from the CosmetAssure database | Any complication (RR 2.05) | Hematoma (RR 3.38) | ||||
| Gupta et al15 | Five-year prospective cohort review of 73,608 cases from the CosmetAssure database | Major complications (RR 1.01); Hematoma (RR 1.01); SSI (RR 1.02) | SSI (RR 1.09) | ||||
| Winocour et al16,36 | 25,478 abdominoplasties over a 5-year period from the CosmetAssure database | Major complications (RR 1.4) | Major complications (RR 1.3) | Major complications (RR 1.5) | Major complications (RR 1.8) | ||
| Bamba et al16 | Five-year prospective cohort review of 129,007 patients from the CosmetAssure database | SSI (RR 1.05), any complication (RR 1.31) | |||||
| Kaoutzanis17 | Five-year prospective cohort review of 129,007 patients from the CosmetAssure database | SSI (RR 1.58) | SSI (RR 1.61) | SSI (RR 1.01) | SSI (RR 1.07) | SSI (RR 1.88) | |
| Pluvy et al25 | Systematic review of 60 randomized, controlled observational studies | Cutaneous necrosis (RR 0.76); DWH (RR 0.71); Epidermolysis (RR 0.92); SSI (RR 0.70) | |||||
DWH, delayed wound healing; SSI, surgical site infection; PE, pulmonary embolism.